Table 3.
Association between race and prognostic factors at diagnosis.
Stage (III, IV)/(I, II) OR (95% CI) | N1, N2, N3/N0 OR (95% CI) | |
---|---|---|
All sitesa (n = 326) | ||
White | 1.00 (reference) | 1.00 (reference) |
Black | 1.47 (0.82-2.65) | 1.36 (0.78-2.36) |
Oral Cavityb (n = 113) | ||
White | 1.00 (reference) | 1.00 (reference) |
Black | 3.60 (0.97-13.41) | 1.28 (0.41-4.00) |
Pharynxb* (n = 104) | ||
White | 1.00 (reference) | 1.00 (reference) |
Black | 1.38 (0.32-6.06) | 1.12 (0.33-3.83) |
Larynxb (n = 109) | ||
White | 1.00 (reference) | 1.00 (reference) |
Black | 1.10 (0.45-2.72) | 2.26 (0.92-5.61) |
Adjusted for age, any tobacco use, gender, family history of cancer, alcohol use, socioeconomic status, insurance and tumor site
Adjusted for age, any tobacco use, gender, family history of cancer, alcohol use, socioeconomic status and insurance
tobacco eliminated from the model for advanced stage due to collinearity